Primary renal cell carcinoma: relationship between 18F-FDG uptake and response to neoadjuvant sorafenib. [electronic resource]
Producer: 20121206Description: 967-73 p. digitalISSN:- 1473-5628
- Adult
- Aged
- Aged, 80 and over
- Benzenesulfonates -- adverse effects
- Biological Transport
- Carcinoma, Renal Cell -- diagnostic imaging
- Feasibility Studies
- Female
- Fluorodeoxyglucose F18 -- metabolism
- Humans
- Kidney Neoplasms -- diagnostic imaging
- Male
- Middle Aged
- Multimodal Imaging
- Neoadjuvant Therapy -- adverse effects
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Positron-Emission Tomography
- Pyridines -- adverse effects
- Safety
- Sorafenib
- Survival Analysis
- Tomography, X-Ray Computed
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.